Average P/FCF Ratio

← P/FCF Ratio

The current P/FCF ratio is N/A as of Monday, May 16, 2022, shown against its trailing averages.

Not enough data

This chart needs at least one available historical value.

ASBP P/FCF Ratio Averages

P/FCF RATIO TODAY

N/A

P/FCF RATIO TTM

N/A

P/FCF RATIO 3Y

N/A

P/FCF RATIO 5Y

N/A

P/FCF RATIO 10Y

N/A

P/FCF RATIO 15Y

N/A

P/FCF RATIO 20Y

N/A

About Aspire Biopharma Holdings, Inc.

Aspire Biopharma Holdings, Inc. is an emerging pharmaceutical enterprise dedicated to pioneering and commercializing innovative sublingual drug delivery systems within the United States. Its flagship product, Instaprin, is an advanced sublingual aspirin formulation known for being soluble, pH neutral, and rapidly absorbed, making it effective for both cardiovascular emergencies and general pain management. The company is diligently developing a diverse pipeline of orally dissolving formulations. This includes a melatonin-based sleep aid, essential vitamins (D, E, and K), testosterone, and semaglutide. Furthermore, Aspire Biopharma is extending its sublingual development efforts to various therapeutic areas, such as anti-nausea treatments, antipsychotic medications, erectile dysfunction drugs, and seizure control therapies, among others. They are also exploring caffeine products, including a formulation for a single-dose sublingual pre-workout supplement. Established in 2021, the firm's main operational base is situated in Estero, Florida.

Estero, FL

2 employees

aspirebiolabs.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Kraig T. Higginson

View full financials